AuxoCell Laboratories Licenses Umbilical Cord Tissue Stem Cell Service to PerkinElmer, Inc. (PKI)’s ViaCord
3/31/2011 10:06:36 AM
CHESTNUT HILL, Mass.--(BUSINESS WIRE)--AuxoCell Laboratories, Inc., a leading stem cell therapeutic and regenerative medicine company, today announced an agreement with PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, to license its stem cell tissue service to ViaCord, PerkinElmer’s family cord blood banking business. This means families can bank newborn stem cells from an additional source – cord tissue.
comments powered by